Middle East and Africa eClinical Solutions Market – Industry Trends and Forecast to 2026
- DAT3308071
- 80 Pages
- October 2019
- Healthcare
Market Segmentation:
By Product {Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Other eClinical Solutions}, Deployment {Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, Licensed Enterprise (On-Premise) Solutions}, Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), End User {Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma & Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies, Academic Institutes}, Country (South Africa and Rest of Middle East and Africa)
Some of the major factors contributing to the growth of the market:
• Rising demands for novel small molecules, bio-therapeutic substances
• Advancement in technology
• Increasing incidence of chronic diseases
Market Players:
The key market players for Middle East and Africa eClinical solutions market are listed below:
• Parexel International Corporation
• Oracle
• Medidata Solutions, Inc.
• Veeva Systems
• ERT Clinical
• eClinical Solutions LLC
• IBM Corporation
• eClinicalWorks
• Bioclinica
• ArisGlobal
• Advarra
• Anju Software, Inc.
• Bio-Optronics, Inc.
• DATATRAK Int.
• ICON plc
• MasterControl, Inc.
• MaxisIT
• OmniComm Systems, Inc.
• RESONANCE HEALTH
• The Realtime Group
• Signant Health
• Xybion Corporation
• Others
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS
3.1.2 RISING GOVERNMENT INITIATIVES
3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION
3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
3.2 RESTRAINTS
3.2.1 DEARTH OF TRAINED PROFESSIONALS
3.2.2 HIGH IMPLEMENTATION COST
3.3 OPPORTUNITIES
3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
3.3.2 TECHNOLOGICAL ADVANCEMENT
3.4 CHALLENGES
3.4.1 STRINGENT REGULATIONS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)
6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)
6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA)
6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM
6.7 SAFETY SOLUTIONS
6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
6.9 CLINICAL DATA INTEGRATION PLATFORMS
6.10 CLINICAL ANALYTICS PLATFORMS
6.11 OTHER ECLINICAL SOLUTIONS
7 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE
7.1 OVERVIEW
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
7.3 CLOUD-BASED (SAAS) SOLUTIONS
7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS
8 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
8.1 OVERVIEW
8.2 PHASE III
8.3 PHASE II
8.4 PHASE IV
8.5 PHASE I
9 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONSMARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS/HEALTHCARE PROVIDERS
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4 ACADEMIC INSTITUTES
9.5 PHARMA & BIOTECH ORGANIZATIONS
9.6 MEDICAL DEVICE MANUFACTURERS
9.7 CONSULTING SERVICE COMPANIES
10 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY
10.1 MIDDLE EAST AND AFRICA
10.1.1 SOUTH AFRICA
10.1.2 REST OF MIDDLE EAST AND AFRICA
10.1.3 EGYPT
10.1.4 SAUDI ARAIA
10.1.5 UNITED ARAB EMIRATES
10.1.6 ISRAEL
11 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
12 COMPANY PROFILE
12.1 ORACLE
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 MEDIDATA SOLUTIONS
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 COMPANY SNAPSHOT
12.3.2 COMPANY SHARE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENTS
12.4 BIOCLINICA
12.4.1 COMPANY SNAPSHOT
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS
12.5 ERT CLINICAL
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENTS
12.6 ARIS MIDDLE EAST AND AFRICA
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 ADVARRA
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 ANJU SOFTWARE
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 BIO-OPTRONICS, INC
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.10 DATATRAK INT.
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 SOLUTION PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 ECLINICALWORKS
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENTS
12.12 ECLINICAL SOLUTIONS LLC
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 IBM CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 ICON PLC
12.14.1 COMPANY SNAPSHOT
12.14.2 REVENUE ANALYSIS
12.14.3 SERVICE PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 MASTERCONTROL, INC.
12.15.1 COMPANY SNAPSHOT
12.15.2 SOLUTION PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 MAXISIT
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENT
12.17 OMNICOMM SYSTEMS, INC
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 PRODUCT PORTFOLIO
12.17.4 RECENT DEVELOPMENTS
12.18 RESONANCE HEALTH
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 REALTIME
12.19.1 COMPANY SNAPSHOT
12.19.2 PRODUCT PORTFOLIO
12.19.3 RECENT DEVELOPMENT
12.20 SIGNANT HEALTH
12.20.1 COMPANY SNAPSHOT
12.20.2 SOLUTION PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
12.21 VEEVA SYSTEMS
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 XYBION CORPORATION
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
UU
TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS
TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
TABLE 3 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 35 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
TABLE 36 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
TABLE 37 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
TABLE 38 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 39 REST OF MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
